Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

The steroid solution can regrow hair but often causes skin issues and doesn't work long-term.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Cyclosporine A can help some people with severe alopecia areata regrow hair.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.

Psychological interventions can improve mental health and quality of life in people with alopecia.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Personality traits and anxiety affect hair loss patients' quality of life.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Emotional symptoms from alopecia areata reduce work productivity and daily activity.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

MCHR2 gene duplications may be linked to alopecia areata.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Pediatric alopecia areata is rare, affecting more girls than boys, and peaks at ages 9-12.

Low vitamin D can worsen pediatric alopecia areata.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

The combined therapy was effective and safe for children with severe alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.